维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Satouchi"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial显示文摘	Tetsuya Mitsudomi Satoshi Morita Yasushi Yatabe Shunichi Negoro Isamu Okamoto Junji Tsurutani Takashi Seto Miyako Satouchi Hirohito Tada Tomonori Hirashima Kazuhiro Asami Nobuyuki Katakami Minoru Takada Hiroshige Yoshioka Kazuhiko Shibata Shinzoh Kudoh Ei	2010	Lancet Oncology2010，，2：	8
2	Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer ( NSCLC ) treated with gefitinib 显示文摘	Satouchi M Negoro S Funada Y et at	2007	Br J Cancer2007，96，8：	1
3	Randomized phase IIstudy of two different schedules of gemcitabine and oral S-1 inchemo-naive patients with advanced non-small cell lung cancer显示文摘	Satouchi M Kotani Y Katakami N	2008	J Clin Oncol2008，26，：	1
4	Digestibility,absorptivity,and physiological effects of cellooligosaccharides in human and rat显示文摘	Satouchi M Watanabe T Wakabayashi S	1996	Journal of Japanese Society for Nutritional Food Science1996，49，：	1
5	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial显示文摘	Tetsuya Mitsudomi Satoshi Morita Yasushi Yatabe Shunichi Negoro Isamu Okamoto Junji Tsurutani Takashi Seto Miyako Satouchi Hirohito Tada Tomonori Hirashima Kazuhiro Asami Nobuyuki Katakami Minoru Takada Hiroshige Yoshioka Kazuhiko Shibata Shinzoh Kudoh Ei	2010	Lancet Oncology2010，，2：	1
6	A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109) 显示文摘	HATTORI Y SATOUCHI M SHIMADA T	2015	Lung Cancer2015，87，2：	1
7	CT fluoroscopy-guided bron- choscopic dye marking for resection of small peripheral pulmonary nodules 显示文摘	Endo M Kotani Y Satouchi M	2004	Chest2004，125，5：	1
8	A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor ( EGFR ) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109 ) 显示文摘	Hattori Y Satouchi M Shimada T	2015	Lung Cancer2015，87，2：	1
9	Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy显示文摘	Saeko Hirota Kayoko Tsujino Masahiro Endo Yoshikazu Kotani Miyako Satouchi Tetsuji Kado Yoshio Hishikawa Kayoko Obayashi Yoshiki Takada Michio Kono Mitsuyuki Abe	2001	International Journal of Radiation Oncology Biology Physics2001，，2：	1
10	Inhibitory effect of low-molecular-weight heparin on the bronchoconstriction in ovalbumin-sensitized guinea pigs after antigen exposure显示文摘	Maeda H Yahata T Satouchi M	1995	Arerugi1995，44，11：	1
11	Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLO t rea ted wi thgeni f i t i b 显示文摘	Satouchi M Negoro S Funada Y	2007	Br JCancer2007，96，：	1
12	Effect of the dietary al-pha-linolenate on platelet-activating factor production in rat peri-toneal polymorph nuclear leukocytes显示文摘	Hori T Satouchi K Kobayashi Y		0，，05：	1
13	Inhibitory effect of low-molecular-weight haparin on the broncheconstriction in ovalbumin-sensitized guinea-pigs after antigen exposure 显示文摘	Maeda H Yahata T Satouchi M	1993	Jpn J Allergol1993，44，11：	1
14	Predictive factors associated with prolonged survival in patients with a non-small cell lung cancer (NSCLC) treated with Gefitinib 显示文摘	Satouchi M Negoro S Funada Y	2007	BrJCancer2007，96，8：	1
15	A phase Ⅲ study comparing amrubicin and cisplatin(AP)with irinotecan and cisplatin(IP)for the treatment of extended-stage small cell lung cancer(ED-SCLC):JCOG0509显示文摘	Kotani Y Satouchi M Ando M		0，，：	1
16	Phase Ⅲ study comparing amrubicin plus cisplatin with irinotecan plus cisplatin in the treatment of extensive-disease small-cell lung cancer:JCOG 0509 显示文摘	SATOUCHI M KOTANI Y SHIBATA T	2014	J Clin Oncol2014，32，12：	1
17	Randomized phase III study of platinum-doublet chemotherapy followed by gefitinib versus continued platinum-doublet chemotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of West Japan Thoracic Oncology Group trial 显示文摘	Okamoto TH Kashii T Satouchi M	2008	J Clin Oncol2008，，：	1
18	Predictive factors associated with prolonged survival in patients with advanced non- small-cell lung cancer (NSCLC) treated with gefitinib显示文摘	Satouchi M Negoro S Funada Y	2007	Br J Cancer2007，96，8：	1
19	Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naive patients with advanced non-small cell lung cancer显示文摘	Satouchi M Kotani Y Katakami N	2008	J Clin Oncol2008，，44：	1
20	Predictive factors associated with prolonged survival in patients with advanced non - small - cell lung cancer treated with gefitinib 显示文摘	Satouchi M Negero S Funada Y	2007	Br J Cancer2007，96，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示